| 臺大學術典藏 |
2020-12-18T08:37:38Z |
Trends in the susceptibility of methicillin-resistant Staphylococcus aureus to nine antimicrobial agents, including ceftobiprole, nemonoxacin, and tyrothricin: Results from the Tigecycline in Vitro Surveillance in Taiwan (TIST) study, 2006-2010
|
Lee C.-M.; Lee M.-H.; Chiang P.-C.; Yu K.-W.; Sun W.; Wang L.-S.; Liu J.-W.; Cheng Y.-J.; Liu C.-E.; Kung H.-C.; Yang J.-L.; Pan S.-C.; Shi Z.-Y.; Chen C.-M.; Chen Y.-H.;Liu C.-Y.;Ko W.-C.;Liao C.-H.;Lu P.-L.;Huang C.-H.;Lu C.-T.;Chuang Y.-C.;Tsao S.-M.;Chen Y.-S.;Liu Y.-C.;Chen W.-Y.;Jang T.-N.;Lin H.-C.;Chen C.-M.;Shi Z.-Y.;Pan S.-C.;Yang J.-L.;Kung H.-C.;Liu C.-E.;Cheng Y.-J.;Liu J.-W.;Sun W.;Wang L.-S.;Yu K.-W.;Chiang P.-C.;Lee M.-H.;Lee C.-M.;Hsu G.-J.;Po-Ren Hsueh; Chen Y.-H.; Liu C.-Y.; Ko W.-C.; Liao C.-H.; Lu P.-L.; Huang C.-H.; Lu C.-T.; Chuang Y.-C.; Tsao S.-M.; Chen Y.-S.; Liu Y.-C.; Chen W.-Y.; Jang T.-N.; Lin H.-C.; Hsu G.-J.; PO-REN HSUEH |
| 臺大學術典藏 |
2020-12-18T08:37:12Z |
Role of rifampin for the treatment of bacterial infections other than mycobacteriosis
|
Lee C.-Y.;Huang C.-H.;Lu P.-L.;Ko W.-C.;Chen Y.-H.;Po-Ren Hsueh; Lee C.-Y.; Huang C.-H.; Lu P.-L.; Ko W.-C.; Chen Y.-H.; PO-REN HSUEH |
| 臺大學術典藏 |
2020-12-18T08:37:10Z |
In vitro activity of ceftazidime–avibactam, ceftolozane–tazobactam, and other comparable agents against clinically important Gram-negative bacilli: Results from the 2017 surveillance of multicenter antimicrobial resistance in Taiwan (SMART)
|
Jean S.-S.;Lu M.-C.;Shi Z.-Y.;Tseng S.-H.;Wu T.-S.;Lu P.-L.;Shao P.-L.;Ko W.-C.;Wang F.-D.;Po-Ren Hsueh; Jean S.-S.; Lu M.-C.; Shi Z.-Y.; Tseng S.-H.; Wu T.-S.; Lu P.-L.; Shao P.-L.; Ko W.-C.; Wang F.-D.; PO-REN HSUEH |
| 臺大學術典藏 |
2020-12-18T08:37:03Z |
Antimicrobial activities of ceftazidime-avibactam, ceftolozane-tazobactam, and other agents against escherichia coli, klebsiella pneumoniae, and pseudomonas aeruginosa isolated from intensive care units in Taiwan: Results from the surveillance of multicenter antimicrobial resistance in Taiwan in 2016
|
PO-REN HSUEH; Lee W.-S.; Ko W.-C.; Wu J.-J.; Lu P.-L.; Lin C.-F.; Lee S.S.J.; Tang H.-J.; Lee N.-Y.; Liao C.-H.; Liao C.-H.;Lee N.-Y.;Tang H.-J.;Lee S.S.J.;Lin C.-F.;Lu P.-L.;Wu J.-J.;Ko W.-C.;Lee W.-S.;Po-Ren Hsueh |
| 臺大學術典藏 |
2020-12-18T08:36:57Z |
Nationwide surveillance of antimicrobial resistance among clinically important Gram-negative bacteria, with an emphasis on carbapenems and colistin: Results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) in 2018
|
Chen Y.-H.; Sheng W.-H.; Lee C.-M.; Liao M.-H.; PO-REN HSUEH; Lee Y.-L.;Lu M.-C.;Shao P.-L.;Lu P.-L.;Chen Y.-H.;Cheng S.-H.;Ko W.-C.;Lin C.-Y.;Wu T.-S.;Yen M.-Y.;Wang L.-S.;Liu C.-P.;Lee W.-S.;Shi Z.-Y.;Chen Y.-S.;Wang F.-D.;Tseng S.-H.;Lin C.-N.;Chen Y.-H.;Sheng W.-H.;Lee C.-M.;Liao M.-H.;Po-Ren Hsueh; Lee Y.-L.; Lu M.-C.; Shao P.-L.; Lu P.-L.; Chen Y.-H.; Cheng S.-H.; Ko W.-C.; Lin C.-Y.; Wu T.-S.; Yen M.-Y.; Wang L.-S.; Liu C.-P.; Lee W.-S.; Shi Z.-Y.; Chen Y.-S.; Wang F.-D.; Tseng S.-H.; Lin C.-N. |
| 臺大學術典藏 |
2020-12-18T08:36:52Z |
Activity of ceftolozane-tazobactam against Gram-negative pathogens isolated from lower respiratory tract infections in the Asia-Pacific region: SMART 2015-2016
|
Kuo S.-C.;Liu C.-E.;Lu P.-L.;Chen Y.-S.;Lu M.-C.;Ko W.-C.;Po-Ren Hsueh;Chuang Y.-C.;Wang F.-D.;The Smart Asia-Pacific Group; Kuo S.-C.; Liu C.-E.; Lu P.-L.; Chen Y.-S.; Lu M.-C.; Ko W.-C.; PO-REN HSUEH; Chuang Y.-C.; Wang F.-D.; the SMART Asia-Pacific Group |
| 臺大學術典藏 |
2020-12-18T08:36:44Z |
National surveillance of antimicrobial susceptibility of bacteremic gram-negative bacteria with emphasis on community-acquired resistant isolates: Report from the 2019 surveillance of multicenter antimicrobial resistance in Taiwan (SMART)
|
Wang F.-D.; Wu T.-S.; Yen M.-Y.; Wang L.-S.; Liu C.-P.; Lee W.-S.; Chen Y.-S.; Lin C.-Y.; Ko W.-C.; Cheng S.-H.; Chen Y.-H.; Lu P.-L.; Shao P.-L.; Lu M.-C.; Lee Y.-L.; Liu P.-Y.;Lee Y.-L.;Lu M.-C.;Shao P.-L.;Lu P.-L.;Chen Y.-H.;Cheng S.-H.;Ko W.-C.;Lin C.-Y.;Wu T.-S.;Yen M.-Y.;Wang L.-S.;Liu C.-P.;Lee W.-S.;Chen Y.-S.;Wang F.-D.;Tseng S.-H.;Lin C.-N.;Tang H.-J.;Chen Y.-H.;Sheng W.-H.;Lee C.-M.;Liao M.-H.;Po-Ren Hsueh; Liu P.-Y.; Tseng S.-H.; Lin C.-N.; Tang H.-J.; Chen Y.-H.; Sheng W.-H.; Lee C.-M.; Liao M.-H.; PO-REN HSUEH |
| 臺大學術典藏 |
2020-09-30T03:23:27Z |
Preliminary experience of adverse drug reactions, tolerability, and efficacy of a once-daily regimen of antiretroviral combination therapy [2]
|
Chang S.-C.; Chen M.-Y.; Lu P.-L.; CHIEN-CHING HUNG; Hsieh S.-M.; Hsieh S.-M.;Chien-Ching Hung;Lu P.-L.;Chen M.-Y.;Chang S.-C. |
| 臺大學術典藏 |
2020-09-30T03:23:26Z |
Bacteremia due to campylobacter species: High rate of resistance to macrolide and quinolone antibiotics
|
CHIEN-CHING HUNG; Chang S.-C.; Luh K.-T.; Lee C.-Y.; Hsueh P.-R.; Lu P.-L.; Lu P.-L.;Hsueh P.-R.;Chien-Ching Hung;Chang S.-C.;Luh K.-T.;Lee C.-Y. |
| 臺大學術典藏 |
2020-09-30T03:22:43Z |
Multicentre surveillance of prevalence of the 23S rRNA A2058G and A2059G point mutations and molecular subtypes of Treponema pallidum in Taiwan, 2009-2013
|
Wu B.-R.; Yang C.-J.; Tsai M.-S.; Lee K.-Y.; Lee N.-Y.; Huang W.-C.; Wu H.; Lee C.-H.; Chen T.-C.; Ko W.-C.; Lin H.-H.; Lu P.-L.; Chen Y.-H.; Liu W.-C.; Yang S.-P.; Wu P.-Y.; Su Y.-C.; CHIEN-CHING HUNG; Chang S.-Y. |